Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$193K Buy
12,123
+69
+0.6% +$1.07K 0.03% 752
2026
Q1
$163K Hold
12,054
0.03% 647
2025
Q4
$150K Buy
+12,054
New +$130K 0.04% 580

Other funds holding VTRS

Abel Hall LLC's VTRS Position: Q2 2026 in Review

Abel Hall LLC increased its Viatris (VTRS) stake by 0.57% in Q2 2026, buying an estimated $1.07K and bringing the position to 12,123 shares worth $193K. The position accounts for 0.03% of the portfolio, ranked #752.

Abel Hall LLC first reported a position in VTRS in Q4 2025 and has held it in 3 quarters since. 1,028 funds tracked by Wall St. Rank hold VTRS as of Q2 2026.

  • Abel Hall LLC held 12,123 shares of Viatris worth $193K as of Q2 2026.
  • Abel Hall LLC bought 69 Viatris shares in Q2 2026, an estimated $1.07K.
  • Viatris made up 0.03% of Abel Hall LLC's portfolio in Q2 2026, its #752 holding.
  • Abel Hall LLC first reported a position in Viatris in Q4 2025 and has held it in 3 quarters since.
  • 1,028 funds tracked by Wall St. Rank held Viatris as of Q2 2026.

Based on Abel Hall LLC's 13F filing for Q2 2026, filed 24 Jul 2026.